Countering counterfeit drugs with blockchain
Capgemini
SEPTEMBER 1, 2020
In monetary terms, the OECD has deduced that the counterfeit pharmaceutical industry is worth $200 billion annually. Drug counterfeiting both endangers patients and negatively impacts pharmaceutical companies by increasing costs and compromising brand integrity. Blockchain: Key to addressing the issue of counterfeit drugs.
Let's personalize your content